MedPath

Teaching Appropriate Gestational Weight Gain

Not Applicable
Completed
Conditions
Obesity
Interventions
Behavioral: Enhanced Care
Registration Number
NCT02963428
Lead Sponsor
Geisinger Clinic
Brief Summary

The study aims to improve obstetrical care by managing gestational weight gain (GWG) among high risk women in an effort to reduce maternal and fetal complications.

Detailed Description

The project is aimed at teaching women about the appropriate weight gain during pregnancy to optimize health outcomes for mothers and newborn babies. Obese gravida meeting inclusion criteria and none of the exclusion criteria will be offered enrollment in TAGG. Those that consent will be randomized to receive standard of care or enhanced care regarding gestational weight gain.

The primary outcome is the proportion of patients that gain less than 20 lbs over the course of the pregnancy. Secondary outcomes include patient knowledge and expectations, attitude about pregnancy weight gain, self-efficacy of ability to eat healthy, and eating, sleeping and physical activity behavior, perceived stress, psychological factors, patient-experience, involvement in care, and food security.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
218
Inclusion Criteria
  • Pre-pregnancy body mass index of at least 30 kg/m2 (per patient report of weight)
  • Less than 16 weeks gestation
  • Gestational weight gain (GWG) less than < 11 pounds from their pre-pregnancy weight to time of potential study enrollment
  • Singleton gestation
  • Access to a phone
Exclusion Criteria
  • BMI less than 30 kg/m2
  • Gestational age greater than or equal to 16 weeks
  • Active diagnosis of cancer on their electronic health record problem list
  • Acquired immunodeficiency syndrome (AIDS)
  • Palliative medicine patients
  • Multiple gestations
  • GWG in excess of 11 pounds prior to study enrollment
  • Patients with Non-Geisinger prenatal care providers
  • Vegan diet
  • Malabsorptive conditions
  • Previously enrolled in TAGG during prior pregnancy. Patient will be excluded from re-randomization
  • Non-English Speaking

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Enhanced Care (EC)Enhanced CareIn addition to standard of care, the study participants will also receive: i. An initial consult with a licensed, Registered Dietician Nutritionist (RDN); ii. Regular tele-health check-ups (10-20 mins/check-up) with the RDN until delivery; iii. Exposure to personal GWG chart; iv. Letter from physician stating the recommendations for GWG over the course of the pregnancy.
Primary Outcome Measures
NameTimeMethod
Gestational weight gain, adjusting for time in the studyat delivery
Secondary Outcome Measures
NameTimeMethod
Perceived stress measured via Perceived Stress ScaleBaseline through 4-12 weeks postpartum

Perceived Stress will be measured using the Perceived Stress Scale by Cohen et. al.

Patient knowledge and expectations factorsBaseline, 32-34 Weeks Gestation, and 4-12 Weeks Postpartum

Participants will be enrolled at baseline (Less than 16 6/7 weeks gestation) and be given a self-report survey tool developed using validated instruments to complete assessing these constructs. This survey tool will then be administered at 32-34 weeks gestation and 4-12 postpartum assessing end of pregnancy and post-intervention patient knowledge and expectations factors.

Attitude on pregnancy weight gainBaseline, 32-34 Weeks Gestation, and 4-12 Weeks Postpartum

Participants will be enrolled at baseline (Less than 16 6/7 weeks gestation) and be given a self-report survey tool developed using validated instruments to complete assessing these constructs. This survey tool will then be administered at 32-34 weeks gestation and 4-12 postpartum assessing end of pregnancy and post-intervention patient attitudes on pregnancy weight gain.

Neonatal intensive care unit (NICU) admissionsAt Delivery
Rate of gestational weight gainBaseline through 4-12 weeks postpartum
Patient-experience and involvement in careBaseline, 32-34 Weeks Gestation, and 4-12 Weeks Postpartum

Participants will be enrolled at baseline (Less than 16 6/7 weeks gestation) and be given a self-report survey tool developed using validated instruments to complete assessing these constructs. This survey tool will then be administered at 32-34 weeks gestation and 4-12 postpartum assessing end of pregnancy and post-intervention patient experience and involvement in their care.

Cost of TreatmentBaseline through 4-12 Weeks Postpartum

Participant cost of treatment will be assessed utilizing claims data obtained from Geisinger Health Plan to compare the effectiveness of the intervention in reducing cost.

Self-efficacy of healthy eatingBaseline, 32-34 Weeks Gestation, and 4-12 Weeks Postpartum

Participants will be enrolled at baseline (Less than 16 6/7 weeks gestation) and be given a self-report survey tool developed using validated instruments to complete assessing these constructs. This survey tool will then be administered at 32-34 weeks gestation and 4-12 postpartum assessing end of pregnancy and post-intervention patient self-efficacy of healthy eating.

Eating, sleeping and physical activity behaviorBaseline, 32-34 Weeks Gestation, and 4-12 Weeks Postpartum

Participants will be enrolled at baseline (Less than 16 6/7 weeks gestation) and be given a self-report survey tool developed using validated instruments to complete assessing these constructs. This survey tool will then be administered at 32-34 weeks gestation and 4-12 postpartum assessing end of pregnancy and post-intervention patient eating, sleeping and physical activity behaviors.

Diagnosis of gestational diabetes mellitusBaseline through 4-12 Weeks Postpartum

This measure will be obtained using EHR data and analyzed utilizing clinic data points.

Delivery of large for gestational age infantsAt Delivery

This measure will be obtained using electronic health record data and analyzed utilizing clinic data points as well as information gathered from patients through self-report survey data.

Mode of deliveryAt Delivery

Clinical electronic health record data in regards to the participant mode of delivery will be utilized in statistical analyses to determine whether mode of delivery has an impact on other outcomes of interest.

Psychological factors measured via Pregnancy Weight Gain Attitude ScaleBaseline through 4-12 Weeks postpartum

Psychological factors will be assessed using the Pregnancy Weight Gain Attitude Scale by Palmer et. al.

Trial Locations

Locations (1)

Geisinger Health System

🇺🇸

Danville, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath